{"version":"1.0","provider_name":"European Scientist","provider_url":"https:\/\/www.europeanscientist.com\/fr\/","author_name":"Gwladys Johnson","author_url":"https:\/\/www.europeanscientist.com\/fr\/author\/gwladys-johnson\/","title":"Des questions sur Crispr et le g\u00e9nome humain","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"3qiWqbC0GP\"><a href=\"https:\/\/www.europeanscientist.com\/fr\/recherche\/des-questions-sur-crispr-et-le-genome-humain\/\">Des questions sur Crispr et le g\u00e9nome humain<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.europeanscientist.com\/fr\/recherche\/des-questions-sur-crispr-et-le-genome-humain\/embed\/#?secret=3qiWqbC0GP\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0Des questions sur Crispr et le g\u00e9nome humain\u00a0\u00bb &#8212; European Scientist\" data-secret=\"3qiWqbC0GP\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.europeanscientist.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.europeanscientist.com\/wp-content\/uploads\/2020\/07\/dna-2789567_1280.png","thumbnail_width":1207,"thumbnail_height":1280,"description":"L\u2019outil d\u2019\u00e9dition Crispr-Cas9 pourrait se r\u00e9v\u00e9ler dangereux pour le g\u00e9nome humain. C\u2019est le r\u00e9sultat de trois \u00e9tudes r\u00e9cemment publi\u00e9es qui offrent un panorama des risques potentiels li\u00e9s \u00e0 cette pratique.\u00a0 La premi\u00e8re \u00e9tudes a \u00e9t\u00e9 r\u00e9alis\u00e9e par la biologiste Kathy Niakan du Francis Crick Institute de Londres. D\u2019apr\u00e8s la Revue Nature, elle visait \u00e0 utiliser [&hellip;]"}